$PNTG
Pennant Group, Inc.

2023 Q2 Form 10-Q Financial Statement

#000176640023000061 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $132.3M $126.5M
YoY Change 13.73% 11.02%
Cost Of Revenue $105.8M $100.9M
YoY Change 15.75% 11.64%
Gross Profit $26.47M $25.59M
YoY Change 6.31% 8.64%
Gross Profit Margin 20.01% 20.24%
Selling, General & Admin $8.791M $19.63M
YoY Change -56.21% -2.06%
% of Gross Profit 33.21% 76.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.211M $1.280M
YoY Change -4.19% 11.6%
% of Gross Profit 4.58% 5.0%
Operating Expenses $8.791M $20.91M
YoY Change -58.84% -1.32%
Operating Profit $6.261M $4.280M
YoY Change -301.0% 84.01%
Interest Expense $1.453M $1.406M
YoY Change 76.98% 123.53%
% of Operating Profit 23.21% 32.85%
Other Income/Expense, Net $35.00K $30.00K
YoY Change -200.0% 900.0%
Pretax Income $4.843M $2.904M
YoY Change -221.96% 70.82%
Income Tax $1.921M $907.0K
% Of Pretax Income 39.67% 31.23%
Net Earnings $2.797M $1.850M
YoY Change -204.52% 82.45%
Net Earnings / Revenue 2.11% 1.46%
Basic Earnings Per Share $0.09 $0.06
Diluted Earnings Per Share $0.09 $0.06
COMMON SHARES
Basic Shares Outstanding 29.74M shares 29.71M shares
Diluted Shares Outstanding 30.19M shares 30.15M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.838M $2.952M
YoY Change -11.31% -18.61%
Cash & Equivalents $2.838M $2.952M
Short-Term Investments
Other Short-Term Assets $11.55M $13.14M
YoY Change -36.83% -37.33%
Inventory
Prepaid Expenses
Receivables $57.25M $50.66M
Other Receivables $0.00 $0.00
Total Short-Term Assets $71.64M $66.75M
YoY Change -4.02% -18.11%
LONG-TERM ASSETS
Property, Plant & Equipment $27.25M $26.95M
YoY Change 21.54% 50.2%
Goodwill $83.61M $79.50M
YoY Change 11.81% 7.05%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.15M $12.02M
YoY Change -15.61% 60.09%
Total Long-Term Assets $443.8M $441.4M
YoY Change 5.21% 3.63%
TOTAL ASSETS
Total Short-Term Assets $71.64M $66.75M
Total Long-Term Assets $443.8M $441.4M
Total Assets $515.4M $508.2M
YoY Change 3.82% 0.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.04M $12.16M
YoY Change -5.35% 11.47%
Accrued Expenses $46.94M $39.39M
YoY Change 7.45% -1.47%
Deferred Revenue $1.819M $1.609M
YoY Change 18.58% 9.6%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $68.48M $65.63M
YoY Change -8.54% -4.34%
LONG-TERM LIABILITIES
Long-Term Debt $59.15M $57.02M
YoY Change 11.33% 0.92%
Other Long-Term Liabilities $7.779M $6.240M
YoY Change 33.55% 17.6%
Total Long-Term Liabilities $7.779M $6.240M
YoY Change 33.55% 17.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.48M $65.63M
Total Long-Term Liabilities $7.779M $6.240M
Total Liabilities $381.7M $378.9M
YoY Change 0.86% -2.71%
SHAREHOLDERS EQUITY
Retained Earnings $25.93M $23.13M
YoY Change 99.79% 47.77%
Common Stock $29.00K $29.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $128.8M $124.4M
YoY Change
Total Liabilities & Shareholders Equity $515.4M $508.2M
YoY Change 3.82% 0.14%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $2.797M $1.850M
YoY Change -204.52% 82.45%
Depreciation, Depletion And Amortization $1.211M $1.280M
YoY Change -4.19% 11.6%
Cash From Operating Activities $6.537M $8.996M
YoY Change -27.12% -320.98%
INVESTING ACTIVITIES
Capital Expenditures $1.659M $2.314M
YoY Change -130.32% -3.26%
Acquisitions
YoY Change
Other Investing Activities -$7.241M -$12.00K
YoY Change 938.88% -93.68%
Cash From Investing Activities -$8.900M -$2.326M
YoY Change 44.29% -9.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.249M -$5.797M
YoY Change -169.65% -213.89%
NET CHANGE
Cash From Operating Activities 6.537M $8.996M
Cash From Investing Activities -8.900M -$2.326M
Cash From Financing Activities 2.249M -$5.797M
Net Change In Cash -114.0K $873.0K
YoY Change -73.3% -155.85%
FREE CASH FLOW
Cash From Operating Activities $6.537M $8.996M
Capital Expenditures $1.659M $2.314M
Free Cash Flow $4.878M $6.682M
YoY Change -66.22% -203.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001766400
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38900
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
THE PENNANT GROUP, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3349931
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1675 East Riverside Drive
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Eagle
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83616
CY2023Q1 dei City Area Code
CityAreaCode
(208)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
506-6100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
PNTG
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29740003 shares
CY2023Q1 us-gaap Cash
Cash
2952000 usd
CY2022Q4 us-gaap Cash
Cash
2079000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
573000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
592000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50660000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53420000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13140000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18323000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
66752000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
73822000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26947000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26621000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
264109000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
260868000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1372000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2149000 usd
CY2023Q1 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
10652000 usd
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
10545000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
79497000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
79497000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58827000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58617000 usd
CY2023Q1 us-gaap Assets
Assets
508156000 usd
CY2022Q4 us-gaap Assets
Assets
512119000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12161000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13647000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20495000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23283000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16856000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16633000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16116000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16684000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
65628000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
70247000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250041000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
247042000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6240000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6281000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
57023000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
62892000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
378932000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
386462000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30203000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29729000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30149000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29692000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101334000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99764000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23134000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
21284000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3000 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
65000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
65000 usd
CY2023Q1 pntg Net Parent Investment
NetParentInvestment
124432000 usd
CY2022Q4 pntg Net Parent Investment
NetParentInvestment
121012000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
4792000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
4645000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
129224000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125657000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
508156000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
512119000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126464000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113910000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
102602000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
90261000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9597000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
10051000 usd
CY2023Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
8705000 usd
CY2022Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
10033000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1280000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1147000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-92000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
122184000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
111584000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4280000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2326000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1406000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
629000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1376000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-626000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2904000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1700000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
907000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
542000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1997000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1158000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
144000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1014000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29751000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28572000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30147000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30143000 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125657000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1367000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
129224000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114244000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1014000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
144000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2440000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
90000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117932000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1997000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1158000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-18000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
120000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1280000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1147000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
129000 usd
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
97000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
151000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
184000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1367000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2440000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
776000 usd
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1749000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3166000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3161000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4317000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4665000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-772000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
367000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2788000 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-794000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1077000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1635000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4722000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
467000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
245000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8996000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4071000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2314000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2392000 usd
CY2023Q1 pntg Payments For Proceeds From Property Reserve Requirements
PaymentsForProceedsFromPropertyReserveRequirements
12000 usd
CY2022Q1 pntg Payments For Proceeds From Property Reserve Requirements
PaymentsForProceedsFromPropertyReserveRequirements
190000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2326000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2582000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
40500000 usd
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
11000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
46500000 usd
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
6000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
203000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
90000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5797000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5090000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
873000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1563000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2079000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5190000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2952000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3627000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1536000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
499000 usd
CY2023Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
30000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
55000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
8927000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
9516000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7489000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
631000 usd
CY2023Q1 pntg Non Cash Adjustment Increase Decrease To Right Of Use Assets And Lease Liabilities
NonCashAdjustmentIncreaseDecreaseToRightOfUseAssetsAndLeaseLiabilities
0 usd
CY2022Q1 pntg Non Cash Adjustment Increase Decrease To Right Of Use Assets And Lease Liabilities
NonCashAdjustmentIncreaseDecreaseToRightOfUseAssetsAndLeaseLiabilities
9349000 usd
CY2023Q1 pntg Adjustment Operating Lease Right Of Use Asset And Operating Lease Liability
AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
0 usd
CY2022Q1 pntg Adjustment Operating Lease Right Of Use Asset And Operating Lease Liability
AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
-33804000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
566000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
720000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. (herein referred to as “Pennant,” the “Company,” “it,” or “its”), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of March 31, 2023, the Company’s subsidiaries operated 96 home health, hospice and home care agencies and 51 senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company’s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated “Company” and “its” assets and activities is not meant to imply, nor should it be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by Pennant.</span></div>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of the Interim Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Interim Financial Statements relate to revenue, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, self-insurance reserves, and income taxes. Actual results could differ from those estimates.
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1014000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29751000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28572000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
396000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
396000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1571000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30147000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30147000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30143000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2002000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1690000 shares
CY2023Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126464000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113910000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
51233000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
54012000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
573000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
592000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50660000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53420000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126464000 usd
CY2023Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
17139000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113910000 usd
CY2022Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
15234000 usd
CY2023Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
17139000 usd
CY2022Q1 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
15234000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1280000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1147000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9597000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
10051000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
CY2023Q1 pntg Start Up Activities Costs
StartUpActivitiesCosts
203000 usd
CY2022Q1 pntg Start Up Activities Costs
StartUpActivitiesCosts
131000 usd
CY2023Q1 pntg Share Based Compensation Expense And Related Taxes
ShareBasedCompensationExpenseAndRelatedTaxes
1419000 usd
CY2022Q1 pntg Share Based Compensation Expense And Related Taxes
ShareBasedCompensationExpenseAndRelatedTaxes
2440000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
32000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q1 pntg Costs Associated With Transitioning Operations
CostsAssociatedWithTransitioningOperations
47000 usd
CY2022Q1 pntg Costs Associated With Transitioning Operations
CostsAssociatedWithTransitioningOperations
-757000 usd
CY2023Q1 pntg Unusual Non Recurring Or Redundant Charges
UnusualNonRecurringOrRedundantCharges
398000 usd
CY2022Q1 pntg Unusual Non Recurring Or Redundant Charges
UnusualNonRecurringOrRedundantCharges
37000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
144000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4280000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2326000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
48974000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47428000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22027000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20807000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26947000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26621000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1275000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
1114000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
79497000 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q1 us-gaap Goodwill
Goodwill
79497000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58827000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58617000 usd
CY2022Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
2017000 usd
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
2244000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1609000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1592000 usd
CY2023Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
3663000 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
4315000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1129000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1027000 usd
CY2023Q1 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
909000 usd
CY2022Q4 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
1479000 usd
CY2023Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
4076000 usd
CY2022Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
3546000 usd
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2713000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2481000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16116000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16684000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1477000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1608000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
57023000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
62892000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
129000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1367000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2440000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1730000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1575000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
27102000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
35658000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
34302000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
33249000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
32662000 usd
CY2023Q1 pntg Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
253638000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
416611000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
149714000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
266897000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16856000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250041000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.076
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
907000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
542000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.312
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.319
CY2023Q1 pntg Number Of Operating Subsidiaries With Reviews Scheduled
NumberOfOperatingSubsidiariesWithReviewsScheduled
9 review
CY2023Q1 pntg Uniform Program Integrity Contractor Suspended Payments
UniformProgramIntegrityContractorSuspendedPayments
5134000 usd
CY2022Q2 pntg Uniform Program Integrity Contractor Number Of Patient Records Under Review
UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview
107 agency
CY2022Q2 pntg Uniform Program Integrity Contractor Period Of Review
UniformProgramIntegrityContractorPeriodOfReview
P10M
CY2022Q2 pntg Uniform Program Integrity Contractor Sampled And Extrapolated Overpayments
UniformProgramIntegrityContractorSampledAndExtrapolatedOverpayments
5134000 usd
CY2023Q1 pntg General And Professional Liability Insurance Retention Limit Per Claim
GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim
150000 usd
CY2023Q1 pntg Corridor As An Additional Out Of Pocket Retention
CorridorAsAnAdditionalOutOfPocketRetention
500000 usd
CY2023Q1 pntg Workers Compensation Insurance Retention Limit Per Claim
WorkersCompensationInsuranceRetentionLimitPerClaim
250000 usd
CY2022Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001766400-23-000061-index-headers.html Edgar Link pending
0001766400-23-000061-index.html Edgar Link pending
0001766400-23-000061.txt Edgar Link pending
0001766400-23-000061-xbrl.zip Edgar Link pending
ceocert-exhibit311q12023.htm Edgar Link pending
ceocert-exhibit321q12023.htm Edgar Link pending
cfocert-exhibit312q12023.htm Edgar Link pending
cfocert-exhibit322q12023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pntg-20230331.htm Edgar Link pending
pntg-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
pntg-20230331_def.xml Edgar Link unprocessable
pntg-20230331_cal.xml Edgar Link unprocessable
pntg-20230331_lab.xml Edgar Link unprocessable
pntg-20230331_pre.xml Edgar Link unprocessable
pntg-20230331_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending